Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00091
|
|||||
| Drug Name |
Dimesna
|
|||||
| Synonyms |
Tavocept (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Diabetic nephropathy [ICD11: GB61] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C4H8Na2O6S4
|
|||||
| Canonical SMILES |
C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-].[Na+].[Na+]
|
|||||
| InChI |
InChI=1S/C4H10O6S4.2Na/c5-13(6,7)3-1-11-12-2-4-14(8,9)10;;/h1-4H2,(H,5,6,7)(H,8,9,10);;/q;2*+1/p-2
|
|||||
| InChIKey |
KQYGMURBTJPBPQ-UHFFFAOYSA-L
|
|||||
| CAS Number |
CAS 16208-51-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 326.4 | Topological Polar Surface Area | 182 | ||
| Heavy Atom Count | 16 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 8 | |||
| PubChem CID | ||||||
| PubChem SID |
104334235
, 120933845
, 121362217
, 125822884
, 126621119
, 126651868
, 126670297
, 135021492
, 137267146
, 14875006
, 151972885
, 160703331
, 163414196
, 164786731
, 172913485
, 175611347
, 176271074
, 184546110
, 184812797
, 187071883
, 196110085
, 198953650
, 223660855
, 225109334
, 226408768
, 249868252
, 250215995
, 252070734
, 252213075
, 252219973
, 252390158
, 252416150
, 43122396
, 50069632
, 50887054
, 57315621
, 8189811
, 92719058
, 93309578
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OAT1 | Transporter Info | Organic anion transporter 1 | Substrate | [2] | |
| OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [2] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | OAT1 | Transporter Info | Km = 636 microM | Human cervical cancer cell line (Hela)-OAT1 | [2] | |
| OAT3 | Transporter Info | Km = 390 microM | Human cervical cancer cell line (Hela)-OAT3 | [2] | ||
| References | ||||||
| 1 | BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts. Eur J Cancer. 2002 May;38(8):1148-56. | |||||
| 2 | In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna. J Clin Pharmacol. 2012 Apr;52(4):530-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.